Vimovo (Naproxen and Esomeprazole magnesium) for Rheumatoid Arthritis | myRAteam

Connect with others who understand.

sign up log in
About myRAteam
Powered By

Vimovo is a prescription drug approved by the U.S. Food and Drug Administration (FDA) to relieve the signs and symptoms of rheumatoid arthritis and decrease the risk of developing gastric ulcers. Vimovo may be also referred to by its drug names, naproxen and esomeprazole magnesium.

Vimovo is a combination of naproxen, a nonsteroidal anti-inflammatory drug (NSAID), and esomeprazole magnesium, a proton pump inhibitor. Vimovo is believed to work by reducing pain and inflammation caused by rheumatoid arthritis and reducing the production of stomach acid.

How do I take it?
Vimovo is generally taken orally twice a day. It is recommended to use the lowest possible dose to relieve symptoms while minimizing the risk of side effects.

Vimovo comes in the form of an oral tablet.

Side effects
The FDA-approved label for Vimovo lists common side effects including inflammation of the stomach lining, indigestion, diarrhea, stomach ulcers, upper abdominal pain, and nausea.

Rare but serious side effects listed for Vimovo include heart attack, stroke, hypertension, congestive heart failure, gastrointestinal events, kidney and liver damage, allergic reactions, and skin reactions.

For more details about this treatment, visit:

Vivomo — Horizon

Vimovo — RxList

Continue with Facebook
Continue with Google
Your privacy is our priority. By continuing, you accept our Terms of Use and Privacy Policy.
Already a Member? Log in